卓珈控股年报2024/25

公司資料主席報告書管理層討論及分析董事及高級管理層之履歷詳情企業管治報告環境、社會及管治報告董事會報告獨立核數師報告綜合損益及其他全面收益表綜合財務狀況表綜合權益變動表綜合現金流量表財務報表附註五年財務摘要目錄 Corporate InformationChairlady’s StatementManagement Discussion and AnalysisBiographical Details of Directors and Senior ManagementCorporate Governance ReportEnvironmental, Social and Governance ReportReport of the DirectorsIndependent Auditor’s ReportConsolidated Statement of Profit or Loss and OtherComprehensive IncomeConsolidated Statement of Financial PositionConsolidated Statement of Changes in EquityConsolidated Statement of Cash FlowsNotes to the Financial StatementsFive-Year Financial SummaryCONTENTS 2592129478296104105107108110188 MIRICOR ENTERPRISES HOLDINGS LIMITED/ Annual Report 2025CORPORATE INFORMATION公司資料Board of directorsExecutive DirectorsMs. LAI Ka Yee Gigi(Chairlady and Chief Executive Officer)Mr. HO Tsz Leung LincolnDr. LAM Ping YanIndependent Non-Executive DirectorsMr. CHENG Fu Kwok DavidMr. CHENG Yuk WoMr. LI Wai KwanAudit committeeMr. CHENG Yuk Wo(Chairman)Mr. CHENG Fu Kwok DavidMr. LI Wai KwanRemuneration committeeMr. CHENG Yuk Wo(Chairman)Ms. LAI Ka Yee GigiMr. LI Wai KwanNomination committeeMs. LAI Ka Yee Gigi(Chairlady)Mr. CHENG Fu Kwok DavidMr. CHENG Yuk WoAuthorised representativesMr. HO Tsz Leung LincolnMr. LO Tai OnCompany secretaryMr. LO Tai OnAuditorErnst & YoungCertified Public AccountantsRegistered Public Interest Entity Auditor27/F, One Taikoo Place979 King’s RoadQuarry BayHong Kong 董事會執行董事黎珈而女士（主席兼行政總裁）何子亮先生林秉恩醫生獨立非執行董事鄭輔國先生鄭毓和先生李偉君先生審核委員會鄭毓和先生（主席）鄭輔國先生李偉君先生薪酬委員會鄭毓和先生（主席）黎珈而女士李偉君先生提名委員會黎珈而女士（主席）鄭輔國先生鄭毓和先生授權代表何子亮先生羅泰安先生公司秘書羅泰安先生核數師安永會計師事務所執業會計師註冊公眾利益實體核數師香港鰂魚涌英皇道979號太古坊一座27樓 CORPORATE INFORMATION公司資料Registered office in Cayman IslandsCricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman IslandsHeadquarters and principal place of businessin Hong Kong18/F, Nan Fung Tower88 Connaught Road CentralCentralHong KongCayman Islands principal share registrarand transfer officeConyers Trust Company (Cayman) LimitedCricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman IslandsHong Kong share registrarTricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong KongPrincipal bankerHang Seng Bank Limited83 Des Voeux Road CentralCentralHong KongThe Bank of East Asia, LimitedShop A–C, G/FEasey Commercial Building253–261 Hennessy RoadWanchaiHong Kong 2025年報/卓珈控股集團有限公司開曼群島註冊辦事處Cricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands香港總部及主要營業地點香港中環干諾道中88號南豐大廈18樓開曼群島主要股份過戶登記處Conyers Trust Company (Cayman) LimitedCricket Square, Hutchins DriveP.O. Box 2681Grand Cayman, KY1-1111Cayman Islands香港股份過戶登記處卓佳證券登記有限公司香港夏愨道16號遠東金融中心17樓主要往來銀行恒生銀行有限公司香港中環德輔道中83號東亞銀行有限公司香港灣仔軒尼詩道253–261號依時商業大廈地下A–C號 MIRICOR ENTERPRISES HOLDINGS LIMITED/ Annual Report 2025CORPORATE INFORMATION公司資料Public relations consultantStrategic Financial Relations Limited2401–2, Admiralty Centre 118 Harcourt Road, Hong KongStock code1827Company websitewww.miricor.com 公關顧問縱橫財經公關顧問有限公司香港夏愨道18號海富中心第一期2401–2室股份代號1827公司網址www.miricor.com CHAIRLADY’S STATEMENT主席報告書Dear Shareholders:This year has been a year full of challenges and opportunities for themedical aesthetic industry in Hong Kong. Against the backdrop ofa complex and volatile global economic environment, Hong Kong’smedical aesthetic market has demonstrated strong resilience andvitality with its professional and regulated system. On behalf ofthe Board of Directors (the“Board”), I would like to present theperformance of the Company and its subsidiaries (collectively referredto as the“Group”) for the year ended 31 March 2025 (“FY2025”) andour future development strategies.FY2025 Performance ReviewIn FY2025, the Group achieved a revenue of HK$403.2 million (For theyear ended 31 March 2024 (“FY2024”): HK$494.3 million), representinga decrease of 18.4% year-on-year. However, the Group managed toimprove its operational efficiency and effectively controlled its operatingcosts thanks to the tireless efforts of the team. Earnings beforeinterest on bank loans, taxes and depreciation of property, plant andequipment for FY2025 was HK$58.6 million (FY2024: HK$31.7 million),representing a year-on-year increase of 84.9%. At the same time, theGroup achieved a turnaround with a net profit of HK$10.6 million forthe FY2025 (FY2024: net loss of HK$12.6 million). During the year,this achievement was made possible by the hard work of our staff, thesupport of our partners and the trust and recognition of our customers.I.Business Performance:•Medical aesthetics and wellness beauty businesses werestable with new treatments introduced to meet customerneeds and emerging consumer trends. We have revampedour loyalty programme to improve customer retention.It has shown that these initiatives have been effective instrengthening business performance.•The skincare retail business suffered a decline in salesdue to the sluggish consumer market, but the Group hasproactively adjusted its strategy and optimized its productportfol